JP2018509460A - 炎症疾患及び免疫疾患を治療するための方法及び組成物 - Google Patents

炎症疾患及び免疫疾患を治療するための方法及び組成物 Download PDF

Info

Publication number
JP2018509460A
JP2018509460A JP2017550556A JP2017550556A JP2018509460A JP 2018509460 A JP2018509460 A JP 2018509460A JP 2017550556 A JP2017550556 A JP 2017550556A JP 2017550556 A JP2017550556 A JP 2017550556A JP 2018509460 A JP2018509460 A JP 2018509460A
Authority
JP
Japan
Prior art keywords
cancer
hypochlorous acid
skin
disease
acid composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017550556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509460A5 (https=
Inventor
サンプソン，マーク
パニチェヴァ，スヴェトラーナ
ショッケメール，キャリー
ソロモン，イーサン
Original Assignee
レルム セラピューティクス，インコーポレイテッド
レルム セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/670,641 external-priority patent/US9999635B2/en
Application filed by レルム セラピューティクス，インコーポレイテッド, レルム セラピューティクス，インコーポレイテッド filed Critical レルム セラピューティクス，インコーポレイテッド
Publication of JP2018509460A publication Critical patent/JP2018509460A/ja
Publication of JP2018509460A5 publication Critical patent/JP2018509460A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2017550556A 2015-03-27 2016-03-28 炎症疾患及び免疫疾患を治療するための方法及び組成物 Pending JP2018509460A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/670,641 2015-03-27
US14/670,641 US9999635B2 (en) 2007-01-16 2015-03-27 Methods and compositions for treating inflammatory disorders
PCT/US2016/024453 WO2016160668A1 (en) 2015-03-27 2016-03-28 Methods and compositions for treating inflammatory and immunological disorders

Publications (2)

Publication Number Publication Date
JP2018509460A true JP2018509460A (ja) 2018-04-05
JP2018509460A5 JP2018509460A5 (https=) 2019-05-09

Family

ID=57006380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017550556A Pending JP2018509460A (ja) 2015-03-27 2016-03-28 炎症疾患及び免疫疾患を治療するための方法及び組成物

Country Status (12)

Country Link
US (2) US10617716B2 (https=)
EP (1) EP3273973A4 (https=)
JP (1) JP2018509460A (https=)
KR (1) KR20180012745A (https=)
CN (1) CN107847520A (https=)
AU (1) AU2016243554A1 (https=)
CA (1) CA2980966A1 (https=)
HK (1) HK1250337A1 (https=)
IL (1) IL254671A0 (https=)
MX (1) MX2017012433A (https=)
SG (1) SG11201707892YA (https=)
WO (1) WO2016160668A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021523124A (ja) * 2018-05-02 2021-09-02 オキュソフト インコーポレイテッドＯＣｕＳＯＦＴ，Ｉｎｃ． 次亜塩素酸をベースにした眼瞼洗浄剤
JP2021171322A (ja) * 2020-04-24 2021-11-01 ニプロ株式会社 次亜塩素酸の呼吸器への導入システム

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
EP3233091A4 (en) 2014-12-16 2018-07-18 Realm Therapeutics, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
ZA201707084B (en) * 2016-10-21 2018-11-28 Ultrapure Hocl Pty Ltd Hypochlorous acid
WO2018230743A1 (ja) * 2017-06-17 2018-12-20 株式会社エースネット ラジカル発生触媒、ラジカルの製造方法、酸化反応生成物の製造方法、薬剤および農畜産用薬剤
CN112703005A (zh) * 2018-07-17 2021-04-23 费灵有限公司 包括微生物群恢复治疗（mrt）组合物的联合疗法
EP3993811B1 (en) * 2019-07-03 2025-02-26 Apr Applied Pharma Research S.A. Therapeutic uses of oxidising hypotonic acid solutions
WO2021235506A1 (ja) * 2020-05-21 2021-11-25 国立大学法人大阪大学 上皮癌治療薬
US20220079981A1 (en) * 2020-09-15 2022-03-17 Facerestoration Ltd Lavage techniques and virucidal compositions comprising hypochlorous solutions
US20220202853A1 (en) * 2020-12-28 2022-06-30 Briotech, Inc. Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies
GB202110146D0 (en) * 2021-07-14 2021-08-25 Hypo Stream Ltd Treatment of respiratory conditions
WO2024183061A1 (zh) * 2023-03-09 2024-09-12 英属维京群岛商白因子国际股份有限公司台湾分公司 一种次氯酸组合物用于制备预防、改善或治疗放射性皮肤炎的医药组合物的用途

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
JP2006505516A (ja) * 2002-07-30 2006-02-16 ノバカル・ファーマシューティカルズ・インコーポレイテッド 生理学的にバランスのとれたイオン化された酸性溶液、および創傷治癒における使用方法
JP2008000099A (ja) * 2006-06-24 2008-01-10 Kamikawa Seisakusho:Kk 家畜用飲料水及び家畜の飼育方法
JP2009523829A (ja) * 2006-01-20 2009-06-25 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた炎症及び過敏症の治療又は予防方法
JP2010534629A (ja) * 2007-07-26 2010-11-11 アザト・ファルマ・アーゲー 電気化学的に活性化された次亜塩素酸塩の溶液を含む医薬製剤
JP2011116730A (ja) * 2009-12-04 2011-06-16 Yasuharu Shima 呼吸器系疾患の予防と治療方法
JP2014518844A (ja) * 2011-03-18 2014-08-07 プリコア，インコーポレイテッド 安定化次亜ハロゲン酸溶液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000063279A (ja) * 1998-08-07 2000-02-29 Medical Discoveries Inc 新規免疫機能向上剤
GB2355190B (en) 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US9168318B2 (en) * 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
CA2602522C (en) * 2005-03-23 2014-09-09 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
EP1959972A4 (en) * 2005-12-13 2009-06-03 Puricore Inc PROCESS FOR TREATING OPEN INJURIES BY HYPOCHLOROUS ACID
CN101405013A (zh) 2006-01-20 2009-04-08 奥古露丝创新科学公司 使用氧化还原电位水溶液治疗或预防腹膜炎的方法
CA2650973A1 (en) 2006-05-03 2007-11-08 University Of Manitoba Microbial markers of inflammatory bowel disease
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
WO2008089268A2 (en) 2007-01-16 2008-07-24 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
KR101715631B1 (ko) 2008-04-01 2017-03-13 안티포딘 파마슈티칼스, 인코포레이티드 피부 관리를 위한 조성물 및 방법
US20120251831A1 (en) * 2009-12-16 2012-10-04 Japan Carlit Co., Ltd Near-infrared absorptive coloring matter and near-infrared absorptive composition
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
JP2006505516A (ja) * 2002-07-30 2006-02-16 ノバカル・ファーマシューティカルズ・インコーポレイテッド 生理学的にバランスのとれたイオン化された酸性溶液、および創傷治癒における使用方法
JP2009523829A (ja) * 2006-01-20 2009-06-25 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた炎症及び過敏症の治療又は予防方法
JP2008000099A (ja) * 2006-06-24 2008-01-10 Kamikawa Seisakusho:Kk 家畜用飲料水及び家畜の飼育方法
JP2010534629A (ja) * 2007-07-26 2010-11-11 アザト・ファルマ・アーゲー 電気化学的に活性化された次亜塩素酸塩の溶液を含む医薬製剤
JP2011116730A (ja) * 2009-12-04 2011-06-16 Yasuharu Shima 呼吸器系疾患の予防と治療方法
JP2014518844A (ja) * 2011-03-18 2014-08-07 プリコア，インコーポレイテッド 安定化次亜ハロゲン酸溶液

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021523124A (ja) * 2018-05-02 2021-09-02 オキュソフト インコーポレイテッドＯＣｕＳＯＦＴ，Ｉｎｃ． 次亜塩素酸をベースにした眼瞼洗浄剤
US11806415B2 (en) 2018-05-02 2023-11-07 Ocusoft, Inc. Hypochlorous acid-based eyelid cleansers
JP2021171322A (ja) * 2020-04-24 2021-11-01 ニプロ株式会社 次亜塩素酸の呼吸器への導入システム

Also Published As

Publication number Publication date
US20180078578A1 (en) 2018-03-22
EP3273973A1 (en) 2018-01-31
US20170360832A1 (en) 2017-12-21
WO2016160668A1 (en) 2016-10-06
AU2016243554A1 (en) 2017-10-19
CN107847520A (zh) 2018-03-27
CA2980966A1 (en) 2016-10-06
SG11201707892YA (en) 2017-10-30
MX2017012433A (es) 2018-03-26
EP3273973A4 (en) 2018-12-05
US10617716B2 (en) 2020-04-14
IL254671A0 (en) 2017-11-30
KR20180012745A (ko) 2018-02-06
HK1250337A1 (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
JP2018509460A (ja) 炎症疾患及び免疫疾患を治療するための方法及び組成物
US10987379B2 (en) Hypochlorous acid formulations and methods for treating skin conditions
US11938166B2 (en) Methods and compositions for treating mucosal tissue disorders
US10632147B2 (en) Methods and compositions for treating inflammatory disorders
JP6753860B2 (ja) リルゾールの舌下製剤
JP2017535612A (ja) リルゾールの舌下投与
JP2018535249A (ja) ランピルナーゼおよび／またはアンフィナーゼを使用するウイルス性結膜炎の処置
RU2718061C1 (ru) Композиции и способы лечения заболеваний носа и слизистой оболочки околоносовых пазух агонистами никотинового ацетилхолинового рецептора
JP6051315B2 (ja) 乾癬を処置するためのピドチモドの使用
WO2026076052A1 (en) Methods of treating headaches and photophobia
Maggs Managing chronic ocular conditions in dogs and cats.
BR112018067718B1 (pt) Composições para tratamento de doenças da mucosa nasal e paranasal com agonistas do receptor de acetilcolina nicotínica

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190327

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200908